Literature DB >> 21546200

Risk factors for false-negative results of QuantiFERON-TB Gold In-Tube assay in non-HIV-infected patients with culture-confirmed tuberculosis.

Eun Young Kim1, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Young Ae Kang.   

Abstract

Limited information is available on the risk factors for false-negative results with the new generation of QuantiFERON-TB Gold In-Tube (QFT-GIT) tests in non-HIV-infected patients with tuberculosis (TB). We sought to identify risk factors for false-negative QFT-GIT results in culture-confirmed TB patients. We reviewed the microbiological, laboratory, radiographic, and clinical data of 362 patients with positive M. tuberculosis cultures who received QFT-GIT tests at a Korean tertiary hospital between September 2006 and March 2010. Of these, 311 (85.9%) had true-positive and 51 (14.1%) had false-negative results. The false-negative group was more likely to have immunosuppressant diseases and lower platelet, protein, and albumin levels than the true-positive group. An immunosuppressive condition was an independent risk factor for false-negative QFT-GIT results in non-HIV-infected patients with active TB (odds ratio, 2.98; 95% confidence interval, 1.38-6.47; P = .006). Careful interpretation of negative QFT-GIT results is thus necessary in immunocompromised patients suspected of having active TB.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21546200     DOI: 10.1016/j.diagmicrobio.2011.02.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Frequent detection of anti-tubercular-glycolipid-IgG and -IgA antibodies in healthcare workers with latent tuberculosis infection in the Philippines.

Authors:  Umme Ruman Siddiqi; Prisca Susan A Leano; Haorile Chagan-Yasutan; Beata Shiratori; Hiroki Saitoh; Yugo Ashino; Yasuhiko Suzuki; Toshio Hattori; Elizabeth Freda O Telan
Journal:  Clin Dev Immunol       Date:  2012-04-05

2.  Factors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study.

Authors:  Yong-Soo Kwon; Yee Hyung Kim; Kyeongman Jeon; Byeong-Ho Jeong; Yon Ju Ryu; Jae Chol Choi; Ho Cheol Kim; Won-Jung Koh
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

3.  Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT®. TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China.

Authors:  Chi Yang; Shaojun Zhang; Lan Yao; Lin Fan
Journal:  J Int Med Res       Date:  2018-03-12       Impact factor: 1.671

4.  Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis.

Authors:  Mari Yamasue; Kosaku Komiya; Yuko Usagawa; Kenji Umeki; Shin-Ichi Nureki; Masaru Ando; Kazufumi Hiramatsu; Hideaki Nagai; Jun-Ichi Kadota
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

5.  Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients.

Authors:  Cengiz Çavuşoğlu; Melike Yaşar-Duman; Mehmet Sezai Taşbakan; Meltem Işıkgöz-Taşbakan; Mehmet Nurullah Orman
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-02-13

6.  Platelets correlate with false negative T-SPOT.TB results by inhibiting interferon-γ production in T cells via degranulation.

Authors:  Jiayue Rao; Yuting Rao; Yang Guo; Mei Jiang; Dan Long; Qing Luo; Zikun Huang; Junming Li
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

7.  Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age.

Authors:  Won Bae; Kyoung Un Park; Eun Young Song; Se Joong Kim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jae-Joon Yim; Choon-Taek Lee; Jae Ho Lee
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.